The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).
 
Laura A. Dawson
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - Raysearch image registration software license
 
Kathryn A. Winter
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - AstraZeneca; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Andrew X. Zhu
Employment - I-Mab
Leadership - I-Mab
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Lilly; Merck; Roche/Genentech; Sanofi
 
Sunil Krishnan
No Relationships to Disclose
 
Chandan Guha
Consulting or Advisory Role - Focused Ultrasound Foundation; Johnson & Johnson; Varian Medical Systems
Research Funding - Celldex; Johnson & Johnson; Myelo Therapeutics GmbH (Inst)
Patents, Royalties, Other Intellectual Property - Montefiore Medical Center
 
Lisa A. Kachnic
Consulting or Advisory Role - New B Innovation
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - UpToDate
 
Michael Gillin
No Relationships to Disclose
 
Theodore S. Hong
Stock and Other Ownership Interests - PanTher Therapeutics
Consulting or Advisory Role - Boston Scientific; Merck; Novocure; Syndax; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); IntraOp (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Timothy Craig
Patents, Royalties, Other Intellectual Property - Licensing agreement with Modus Medical Devices
 
Ali Hosni
(OPTIONAL) Uncompensated Relationships - Elekta
 
Eric Xueyu Chen
Honoraria - AstraZeneca Canada; Bayer; Eisai; Ipsen; Roche Canada
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Nubiyota; Repare Therapeutics; Roche Canada
 
Anne M. Noonan
Consulting or Advisory Role - Eisai; Exelixis; Helsinn Healthcare; QED Therapeutics
 
Eugene Jon Koay
Honoraria - Apollo
Consulting or Advisory Role - Augmenix; RenovoRx
Speakers' Bureau - Oncology Information Group
Research Funding - Elekta; GE Healthcare; Philips Healthcare
Patents, Royalties, Other Intellectual Property - Provisional patent on 3D printed oral stents for radiation treatments of head and neck cancer; Royalties from Taylor and Francis LLC for my co-authored book: An introduction to physical oncology
 
Rishi Sinha
No Relationships to Disclose
 
Michael Lock
No Relationships to Disclose
 
Nitin Ohri
Consulting or Advisory Role - Genentech; Merck
Research Funding - AstraZeneca; Merck (Inst); Reflexion Medical (Inst)
 
Jennifer Anne Dorth
Travel, Accommodations, Expenses - Varian Medical Systems
 
Jennifer Moughan
No Relationships to Disclose
 
Christopher H Crane
No Relationships to Disclose